Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon.

G. Stoter, S. H. Goey, D. Batchelor, A. M. Eggermont, C. Lamers, J. W. Gratama, R. L. Bolhuis

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)225-233
Number of pages9
JournalProgress in clinical and biological research
Volume378
Publication statusPublished - 1992
Externally publishedYes

Cite this